Compound: PLX-4720

Drug Target: BRAF

Drug Target pathway: ERK MAPK signaling

DatasetDatasets
GDSC1: Screened in 96 or 384-well plates with Cyto60 or Resazurin endpoint
GDSC2 (recommended where available): 1536-well plates with CellTiterGlo endpoint
See documentation for more information and screening differences



Tissue specific analysis

PLX-4720 IC50 values for BRAF_mut

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.